Supporting Evidence on Why Health Data Interoperability Still Matters

By December 18, 2016 Blog No Comments

Clinical research is vital for the improvement of society’s healthcare and the medicine offered to the general public. Supporting the effort, clinical trials make it possible to validate the resulting medicine’s appropriateness and effectiveness for patients in need. Still, clinical trial operations are fully aware of the challenges they face on the road towards bringing medicine to market:

  • Antiquated EMR/EHR platforms slow the data flow of information transferred between systems
  • Outdated processes and manual data entry open the door for faulty information
  • Extended setup and break down time heightens the expense of the clinical trial

This is compounded by the reality that clinical trials often require adjustments due to the natural progression of time and technology, or when they demand a change in plan or additional variables, processes often become interrupted (sometimes even unbeknownst to the operators) and new delays threaten the cost and timeline of the planned clinical trial.  We believe interoperability technology solutions help us overcome these obstacles.

 

Technology as the Key to Interoperability

Dr. Janet Woodcock, director of the Center for Drug Evaluation Research at the FDA, has stated that transformational change is constantly needed in order to improve how clinical research is conducted by those who are in the field. This change is not simply to help us keep up with data that we anticipate collecting in the future, but also to help clinical trial operations better organize, assess, and use the date we already have.  This is in line with the FDA’s stance – that health data interoperability may be the key to enhancing clinical trials. “EHRs may have the potential to provide clinical investigators and study personnel access to real-time and longitudinal health care data for review and can facilitate post-trial follow-up on patients to assess long-term safety and efficacy of medical products” the agency states. This is best achieved through validated interoperable clinical trial systems.

 

At the Heart of the Solution

Adaptive Clinical Systems believes that in order to improve the process of doing clinical trials, it is best that data integration must be perceived as more than a rite of passage to bringing medicine to the market.  Instead, clinical trials must be viewed as the necessary means to ensuring the entire cycle of research-to-consumption be in lock-step with current technologies according to the findings within the trial itself. Its effectiveness relies on interoperable clinical trial operations that seek to keep data shared among disparate systems as validated, accurate, up-to-date, and accessible as possible.

It’s a lofty task, but we’ve made it the cornerstone to all that we do at Adaptive Clinical Systems.

 

Contact Us Today to Request a Live Demo